Assenagon Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.53M | Buy |
353,044
+120,097
| +52% | +$1.09M | ﹤0.01% | 728 |
|
|
2026
Q1 | $2.22M | Sell |
232,947
-126,633
| -35% | -$983K | ﹤0.01% | 763 |
|
|
2025
Q4 | $2.8M | Sell |
359,580
-2,733,012
| -88% | -$19.8M | ﹤0.01% | 785 |
|
|
2025
Q3 | $23.5M | Sell |
3,092,592
-528,045
| -15% | -$4.4M | 0.03% | 339 |
|
|
2025
Q2 | $32.4M | Buy |
3,620,637
+3,606,566
| +25,631% | +$33.6M | 0.05% | 285 |
|
|
2025
Q1 | $106K | Hold |
14,071
| – | – | ﹤0.01% | 1130 |
|
|
2024
Q4 | $106K | Hold |
14,071
| – | – | ﹤0.01% | 1293 |
|
|
2024
Q3 | $107K | Sell |
14,071
-50,836
| -78% | -$386K | ﹤0.01% | 1346 |
|
|
2024
Q2 | $401K | Sell |
64,907
-321,978
| -83% | -$1.78M | ﹤0.01% | 1269 |
|
|
2024
Q1 | $1.97M | Sell |
386,885
-142,534
| -27% | -$802K | 0.01% | 904 |
|
|
2023
Q4 | $3.17M | Sell |
529,419
-580,485
| -52% | -$3.36M | 0.01% | 768 |
|
|
2023
Q3 | $7.86M | Sell |
1,109,904
-4,223,010
| -79% | -$30.3M | 0.03% | 446 |
|
|
2023
Q2 | $37.5M | Buy |
5,332,914
+365,077
| +7% | +$2.93M | 0.15% | 134 |
|
|
2023
Q1 | $41.4M | Buy |
4,967,837
+2,377,445
| +92% | +$22.9M | 0.16% | 129 |
|
|
2022
Q4 | $29.7M | Sell |
2,590,392
-25,765
| -1% | -$321K | 0.12% | 194 |
|
|
2022
Q3 | $33M | Sell |
2,616,157
-561,714
| -18% | -$7.23M | 0.14% | 156 |
|
|
2022
Q2 | $33.6M | Buy |
3,177,871
+3,107,027
| +4,386% | +$32.1M | 0.14% | 158 |
|
|
2022
Q1 | $1.15M | Buy |
70,844
+57,608
| +435% | +$924K | ﹤0.01% | 1019 |
|
|
2021
Q4 | $183K | Sell |
13,236
-53,891
| -80% | -$713K | ﹤0.01% | 1381 |
|
|
2021
Q3 | $965K | Sell |
67,127
-687,905
| -91% | -$10.8M | ﹤0.01% | 915 |
|
|
2021
Q2 | $11.9M | Buy |
755,032
+710,563
| +1,598% | +$9.65M | 0.05% | 307 |
|
|
2021
Q1 | $452K | Buy |
+44,469
| New | +$459K | ﹤0.01% | 1042 |
|
|
2020
Q3 | – | Sell |
-303,400
| Closed | -$1.45M | – | 1130 |
|
|
2020
Q2 | $1.45M | Buy |
+303,400
| New | +$1.21M | 0.01% | 690 |
|
|
2020
Q1 | – | Sell |
-74,744
| Closed | -$258K | – | 799 |
|
|
2019
Q4 | $258K | Buy |
+74,744
| New | +$188K | ﹤0.01% | 715 |
|
Other funds holding BCRX
WCM
DA
HWAM
CWS
SW
CWP
VCM
GI
IBOK
SIC